Raymond E. Soccio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Raymond E. Soccio has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Angela H. Weller
Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
2 shared publicationsYachen Shen
Department of Medicine (Y.S., R.E.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia
2 shared publicationsAlessandro Bartolomucci
Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN, USA
1 shared publication- Alexander Pfeifer
Institute of Pharmacology and Toxicology, University Hospital, University of Bonn, 53127 Bonn, Germany
1 shared publication - Alexis H. Bennett
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
1 shared publication - Andreas Kjaer
Rigshospitalet
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis
Top Cited PapersOpen AccessLipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis
- Open Access
- 21 May 2021
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (9) , e3773-e3774
Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
Raymond E Soccio, MD, PhD; Galectin-3 in NAFLD: therapeutic target or non-causal biomarker?, The Journal of Clinical Endocrinology & Metabolism, , dgab363, http
- 21 May 2021
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (9) , e3773-e3774
Open AccessGalectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
Raymond E Soccio, MD, PhD; Galectin-3 in NAFLD: therapeutic target or non-causal biomarker?, The Journal of Clinical Endocrinology & Metabolism, , dgab363, http
- 11 September 2020
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 127 (11) , 1347-1361
ILRUN , a Human Plasma Lipid GWAS Locus, Regulates Lipoprotein Metabolism in Mice
Rationale: Single-nucleotide polymorphisms near the ILRUN (inflammation and lipid regulator with ubiquitin-associated–like and NBR1 [next to BRCA1 gene 1 protein]-like domains) gene are genome-wide significantly associated with plasma lipid traits and coronary artery disease (CAD), but the biological basis of this association is unknown. Objective: To investigate the role of ILRUN in plasma lipid and lipoprotein metabolism. Methods and Results: ILRUN encodes a protein that contains a ubiquitin-associated–like domain, suggesting that it may interact with ubiquitinylated proteins. We generated mice globally deficient for Ilrun and found they had significantly lower plasma cholesterol levels resulting from reduced liver lipoprotein production. Liver transcriptome analysis uncovered altered transcription of genes downstream of lipid-related transcription factors, particularly PPARα (peroxisome proliferator-activated receptor alpha), and livers from Ilrun -deficient mice had increased PPARα protein. Human ILRUN was shown to bind to ubiquitinylated proteins including PPARα, and the ubiquitin-associated–like domain of ILRUN was found to be required for its interaction with PPARα. Conclusions: These findings establish ILRUN as a novel regulator of lipid metabolism that promotes hepatic lipoprotein production. Our results also provide functional evidence that ILRUN may be the casual gene underlying the observed genetic associations with plasma lipids at 6p21 in human.
- 11 September 2020
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 127 (11) , 1347-1361
ILRUN , a Human Plasma Lipid GWAS Locus, Regulates Lipoprotein Metabolism in Mice
Rationale: Single-nucleotide polymorphisms near the ILRUN (inflammation and lipid regulator with ubiquitin-associated–like and NBR1 [next to BRCA1 gene 1 protein]-like domains) gene are genome-wide significantly associated with plasma lipid traits and coronary artery disease (CAD), but the biological basis of this association is unknown. Objective: To investigate the role of ILRUN in plasma lipid and lipoprotein metabolism. Methods and Results: ILRUN encodes a protein that contains a ubiquitin-associated–like domain, suggesting that it may interact with ubiquitinylated proteins. We generated mice globally deficient for Ilrun and found they had significantly lower plasma cholesterol levels resulting from reduced liver lipoprotein production. Liver transcriptome analysis uncovered altered transcription of genes downstream of lipid-related transcription factors, particularly PPARα (peroxisome proliferator-activated receptor alpha), and livers from Ilrun -deficient mice had increased PPARα protein. Human ILRUN was shown to bind to ubiquitinylated proteins including PPARα, and the ubiquitin-associated–like domain of ILRUN was found to be required for its interaction with PPARα. Conclusions: These findings establish ILRUN as a novel regulator of lipid metabolism that promotes hepatic lipoprotein production. Our results also provide functional evidence that ILRUN may be the casual gene underlying the observed genetic associations with plasma lipids at 6p21 in human.
- Open Access
- 1 March 2020
- Published by Elsevier in Cell Reports
- Vol. 30 (9) , 3079-3091.e5
Shared PPARα/γ Target Genes Regulate Brown Adipocyte Thermogenic Function
- 1 March 2020
- Published by Elsevier in Cell Reports
- Vol. 30 (9) , 3079-3091.e5
Open AccessShared PPARα/γ Target Genes Regulate Brown Adipocyte Thermogenic Function
- 28 October 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (46) , 23232-23242
Natural human genetic variation determines basal and inducible expression of PM20D1 , an obesity-associated gene
Significance: Generation of heat by brown and beige fat cells is a potential avenue to increased energy expenditure, and thus management of obesity and metabolic syndrome. PM20D1 plays a role in thermogenesis based on mouse studies, but its expression had not been investigated in human adipocytes. Here we show that human PM20D1 expression is genetically variable at 2 levels. Genotype at certain distant variants correlates with overall PM20D1 expression levels across all human tissues (an “on/off switch”), while a different variant near the gene determines its regulation specifically in adipocytes by the PPARγ receptor and the antidiabetic drugs that target it (a “rheostat”). Human regulatory genetic variation in PM20D1 expression is associated with obesity and may ultimately inform individualized medicine approaches.
- 28 October 2019
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (46) , 23232-23242
Natural human genetic variation determines basal and inducible expression of PM20D1 , an obesity-associated gene
Significance: Generation of heat by brown and beige fat cells is a potential avenue to increased energy expenditure, and thus management of obesity and metabolic syndrome. PM20D1 plays a role in thermogenesis based on mouse studies, but its expression had not been investigated in human adipocytes. Here we show that human PM20D1 expression is genetically variable at 2 levels. Genotype at certain distant variants correlates with overall PM20D1 expression levels across all human tissues (an “on/off switch”), while a different variant near the gene determines its regulation specifically in adipocytes by the PPARγ receptor and the antidiabetic drugs that target it (a “rheostat”). Human regulatory genetic variation in PM20D1 expression is associated with obesity and may ultimately inform individualized medicine approaches.